Document is current
Any future updates will be listed below
-
Authors
Riegman, Michelle https://orcid.org/0000-0001-7381-015X
Sagie, Liran
Galed, Chen https://orcid.org/0000-0003-3186-0428
Levin, Tom https://orcid.org/0000-0002-0369-1711
Steinberg, Noah https://orcid.org/0000-0003-1337-1479
Dixon, Scott J. https://orcid.org/0000-0001-6230-8199
Wiesner, Ulrich https://orcid.org/0000-0001-6934-3755
Bradbury, Michelle S. https://orcid.org/0000-0003-3147-4391
Niethammer, Philipp https://orcid.org/0000-0003-4175-4012
Zaritsky, Assaf https://orcid.org/0000-0002-1477-5478
Overholtzer, Michael https://orcid.org/0000-0003-3007-4986
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM122923)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM099970)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM127356)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA154649)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 28 January 2020
Accepted: 24 July 2020
First Online: 31 August 2020
Competing interests
: Memorial Sloan-Kettering Cancer Center and three investigators involved in this study (M.S.B., U.W. and M.O.) have financial interests in Elucida Oncology. Research involving C′ dots may involve one or more US or international patent applications.
